These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33241993)

  • 41. Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults.
    Waubant E; Chabas D; Okuda DT; Glenn O; Mowry E; Henry RG; Strober JB; Soares B; Wintermark M; Pelletier D
    Arch Neurol; 2009 Aug; 66(8):967-71. PubMed ID: 19667217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinico-radiological dissociation of disease activity in MS patients: frequency and clinical relevance.
    van Faals NL; Dekker I; Balk LJ; Moraal B; Barkhof F; Uitdehaag BMJ; Killestein J; Wattjes MP
    J Neurol; 2020 Nov; 267(11):3287-3291. PubMed ID: 32564152
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple sclerosis lesions in motor tracts from brain to cervical cord: spatial distribution and correlation with disability.
    Kerbrat A; Gros C; Badji A; Bannier E; Galassi F; Combès B; Chouteau R; Labauge P; Ayrignac X; Carra-Dalliere C; Maranzano J; Granberg T; Ouellette R; Stawiarz L; Hillert J; Talbott J; Tachibana Y; Hori M; Kamiya K; Chougar L; Lefeuvre J; Reich DS; Nair G; Valsasina P; Rocca MA; Filippi M; Chu R; Bakshi R; Callot V; Pelletier J; Audoin B; Maarouf A; Collongues N; De Seze J; Edan G; Cohen-Adad J
    Brain; 2020 Jul; 143(7):2089-2105. PubMed ID: 32572488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis.
    Cocozza S; Pontillo G; Lanzillo R; Russo C; Petracca M; Di Stasi M; Paolella C; Vola EA; Criscuolo C; Moccia M; Lamberti A; Monti S; Brescia Morra V; Elefante A; Palma G; Tedeschi E; Brunetti A
    Neuroradiology; 2019 Feb; 61(2):155-162. PubMed ID: 30617409
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natalizumab therapy for highly active pediatric multiple sclerosis.
    Kornek B; Aboul-Enein F; Rostasy K; Milos RI; Steiner I; Penzien J; Hellwig K; Pitarokoili K; Storm van's Gravesande K; Karenfort M; Blaschek A; Meyer A; Seidl R; Debelic D; Vass K; Prayer D; Kristoferitsch W; Bayas A
    JAMA Neurol; 2013 Apr; 70(4):469-75. PubMed ID: 23420110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis.
    Yeh EA; Weinstock-Guttman B; Ramanathan M; Ramasamy DP; Willis L; Cox JL; Zivadinov R
    Brain; 2009 Dec; 132(Pt 12):3392-400. PubMed ID: 19892770
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Barkhof magnetic resonance imaging criteria predict early relapse in pediatric multiple sclerosis.
    Neuteboom RF; Ketelslegers IA; Boon M; Catsman-Berrevoets CE; Hintzen RQ;
    Pediatr Neurol; 2010 Jan; 42(1):53-5. PubMed ID: 20004863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term disability progression of pediatric-onset multiple sclerosis.
    McKay KA; Hillert J; Manouchehrinia A
    Neurology; 2019 Jun; 92(24):e2764-e2773. PubMed ID: 31092624
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis.
    Papadopoulos K; Tozer DJ; Fisniku L; Altmann DR; Davies G; Rashid W; Thompson AJ; Miller DH; Chard DT
    Mult Scler; 2010 Apr; 16(4):427-33. PubMed ID: 20086026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis.
    Burgetova A; Dusek P; Vaneckova M; Horakova D; Langkammer C; Krasensky J; Sobisek L; Matras P; Masek M; Seidl Z
    AJNR Am J Neuroradiol; 2017 Jun; 38(6):1079-1086. PubMed ID: 28450431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pediatric multiple sclerosis.
    Chabas D; Strober J; Waubant E
    Curr Neurol Neurosci Rep; 2008 Sep; 8(5):434-41. PubMed ID: 18713581
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and transcriptional recovery profiles in pediatric and adult multiple sclerosis patients.
    Menascu S; Khavkin Y; Zilkha-Falb R; Dolev M; Magalashvili D; Achiron A; Gurevich M
    Ann Clin Transl Neurol; 2021 Jan; 8(1):81-94. PubMed ID: 33197148
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of fingolimod after switching from interferon β-1a in an adolescent with multiple sclerosis: case report.
    Amidei A; Siciliano G; Pasquali L
    Neurol Sci; 2021 May; 42(Suppl 1):5-7. PubMed ID: 33723709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis.
    Prosperini L; Gallo V; Petsas N; Borriello G; Pozzilli C
    Eur J Neurol; 2009 Nov; 16(11):1202-9. PubMed ID: 19538207
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study.
    Thompson AJ; Kermode AG; MacManus DG; Kendall BE; Kingsley DP; Moseley IF; McDonald WI
    BMJ; 1990 Mar; 300(6725):631-4. PubMed ID: 2138923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.
    van Walderveen MA; Lycklama A Nijeholt GJ; Adèr HJ; Jongen PJ; Polman CH; Castelijns JA; Barkhof F
    Arch Neurol; 2001 Jan; 58(1):76-81. PubMed ID: 11176939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo.
    Absinta M; Sati P; Masuzzo F; Nair G; Sethi V; Kolb H; Ohayon J; Wu T; Cortese ICM; Reich DS
    JAMA Neurol; 2019 Dec; 76(12):1474-1483. PubMed ID: 31403674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Teriflunomide for multiple sclerosis.
    He D; Zhang C; Zhao X; Zhang Y; Dai Q; Li Y; Chu L
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009882. PubMed ID: 27003123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Datta G; Colasanti A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Van Vlierberghe E; Van Hecke W; Searle G; Santos-Ribeiro A; Matthews PM
    Brain; 2017 Nov; 140(11):2927-2938. PubMed ID: 29053775
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis.
    Pelletier J; Suchet L; Witjas T; Habib M; Guttmann CR; Salamon G; Lyon-Caen O; Chérif AA
    Arch Neurol; 2001 Jan; 58(1):105-11. PubMed ID: 11176943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.